Connie Celum

Professor, Global Health
Professor, Medicine
Adjunct Professor, Epidemiology

Contact

International Clinical Research Center
Cabrini Medical Tower, Suite 1300
901 Boren Avenue
Seattle, WA
98104

206-520-3825
206-520-3831 (Fax)
ccelum@u.washington.edu

Education

MD University of California (San Francisco)
MPH University of Washington
BA Stanford University

Projects

Tenofovir and Emtricitabine/Tenofovir Chemoprophylaxis to Prevent HIV Acquisition Health issue: HIV/AIDSKenya, UgandaProject type: Research

Immune Correlates of HIV ProtectionHealth issue: HIV/AIDSSouth Africa, UgandaProject type: Research

Prospective Study of Pharmacokinetics, Clinical and Virologic Response to Acyclovir Episodic Therapy for Genital Herpes Ulcers in HIV Negative African WomenHealth issue: HIV/AIDSSouth Africa, Zambia, ZimbabweProject type: Research

HPTN 039 (Herpes Acquisition)Health issue: HIV/AIDS; STDs (other than HIV)Peru, South Africa, ZambiaProject type: Research

MP3 Prevention Rx (HIV Prevention)Health issue: HIV/AIDSUgandaProject type: Research

Partners PrEP Study (HIV Prevention)Health issue: HIV/AIDSKenya, UgandaProject type: Research

Partners in Prevention HSV/HIV Transmission Study (Herpes Transmission )Health issue: HIV/AIDSBotswana, Kenya, Rwanda, South Africa, Tanzania, United Republic of, Uganda, ZambiaProject type: Research

Selected Publications

For publications and more information, go to Dr. Celum's Medicine Homepage: http://depts.washington.edu/uwicrc/about/staff/celum.html
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L; HPTN 039 Protocol Team.
Lancet. 2008 Jun 21;371(9630):2109-19.
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, Kanweka W, Allen S, Kiarie JN, Makhema J, Were E, Manongi R, Coetzee D, de Bruyn G, Delany-Moretlwe S, Magaret A, Mugo N, Mujugira A, Ndase P, Celum C; Partners in Prevention HSV-2/HIV Transmission Study Group.
PLoS ONE. 2008 Jan 9;3(1):e1411.

Expertise

HIV prevention and vaccine trials

Health Issues

HIV/AIDS; STDs (other than HIV)

Country Affiliations

Botswana, Kenya, Peru, Rwanda, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe

Languages Spoken

Spanish